Agenus AGEN
NASDAQ AGEN
$8.23 -0.01 (-0.12%)
As of: Sep 4, 2026 · 12:52 PM EDT

Agenus (AGEN) Consolidated Net Income (2010 - 2026)

Agenus (AGEN) posted quarterly Consolidated Net Income of $364000.0 for Q1 2026, up 101.38% year-over-year from $180748.9 in Q1 2025, and up 122.05% quarter-over-quarter from -$1.7 million in Q4 2025.

Analysis

Agenus (AGEN) Consolidated Net Income (2010 - 2026) Analysis & Trends

Agenus' Consolidated Net Income history runs 17 years deep, the most recent figure standing at $364000.0 for Q1 2026.

  • In Q1 2026, Consolidated Net Income rose 101.38% year-over-year to $364000.0; the TTM figure through Mar 2026 stood at -$38.3 million (up 81.22% YoY), while the FY2025 annual figure was -$415.1 million, up 20.05% from the prior year.
  • Consolidated Net Income for Q1 2026 stood at $364000.0, up from -$1.7 million in the prior quarter.
  • The five-year high for Consolidated Net Income was $364000.0 in Q1 2026, with the low at -$105.5 million in Q4 2023.
  • The 5-year median for Consolidated Net Income is -$46.7 million (2023), against an average of -$44.1 million.
  • The sharpest annual moves came in 2022 and 2026: Consolidated Net Income plunged 131.71% in 2022, then soared 101.38% in 2026.
  • Agenus' Consolidated Net Income stood at -$58.1 million in 2022, then plunged by 81.78% to -$105.5 million in 2023, then jumped by 55.45% to -$47.0 million in 2024, then jumped by 96.49% to -$1.7 million in 2025, then surged by 122.05% to $364000.0 in 2026.
  • Business Quant data shows AGEN's Consolidated Net Income at $364000.0 in Q1 2026, -$1.7 million in Q4 2025, and -$7.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn 601.00 Mn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -644.37 Mn
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn - 81.49 Mn
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -13.27 Mn
10 Agenus 340.21 Mn 340.21 Mn 34.52 Mn -3.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.95 Mn
Mar 31, 2026 385,000.00
Dec 31, 2025 -1.62 Mn
Sep 30, 2025 -17.72 Mn
Jun 30, 2025 -30.00 Mn
Mar 31, 2025 -26.11 Mn
Dec 31, 2024 -46.58 Mn
Sep 30, 2024 -67.23 Mn
Jun 30, 2024 -61.94 Mn
Mar 31, 2024 -62.35 Mn
Dec 31, 2023 -48.38 Mn
Sep 30, 2023 -64.97 Mn
Jun 30, 2023 -73.19 Mn
Mar 31, 2023 -70.93 Mn
Dec 31, 2022 -75.08 Mn
Sep 30, 2022 -57.25 Mn
Jun 30, 2022 -58.30 Mn
Mar 31, 2022 -50.66 Mn
Dec 31, 2021 -70.60 Mn
Sep 30, 2021 170.96 Mn